1. Home
  2. GOSS vs IROQ Comparison

GOSS vs IROQ Comparison

Compare GOSS & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.43

Market Cap

101.2M

Sector

Health Care

ML Signal

HOLD

Logo IF Bancorp Inc.

IROQ

IF Bancorp Inc.

HOLD

Current Price

$26.55

Market Cap

91.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
IROQ
Founded
2015
1883
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
101.2M
91.6M
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
GOSS
IROQ
Price
$0.43
$26.55
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$4.91
N/A
AVG Volume (30 Days)
25.1M
21.7K
Earning Date
03-17-2026
05-05-2026
Dividend Yield
N/A
1.48%
EPS Growth
N/A
140.35
EPS
N/A
0.84
Revenue
$48,471,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$31.61
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$23.01
52 Week High
$3.87
$29.00

Technical Indicators

Market Signals
Indicator
GOSS
IROQ
Relative Strength Index (RSI) 23.44 34.35
Support Level $0.33 $23.86
Resistance Level $0.60 $26.99
Average True Range (ATR) 0.06 0.23
MACD 0.06 -0.15
Stochastic Oscillator 22.86 2.98

Price Performance

Historical Comparison
GOSS
IROQ

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.

Share on Social Networks: